Russia has developed an mRNA vaccine for cancer, as reported by the Russian news agency TASS. The vaccine will be provided free of charge to cancer patients, Andrey Kaprin, General Director of the Radiology Medical Research Center under the Russian Ministry of Health, stated in an interview with Radio Rossiya.
Developed in collaboration with multiple research centers, the vaccine is expected to be available to the public by early 2025. Pre-clinical trials have demonstrated that the vaccine effectively suppresses tumor growth and potential metastases, according to Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology.
What Is an mRNA Vaccine?
mRNA, or messenger RNA, vaccines work by delivering instructions to cells to produce a protein—or a fragment of it—similar to that of the virus or infectious agent. This protein stimulates an immune response, enabling the body to recognize and fight the actual pathogen.